U.S. health officials recently explored whether certain selective serotonin reuptake inhibitors, or SSRIs, could face restrictions as Health Secretary Robert F. Kennedy Jr. prepared a broader initiative...
The FDA's latest proposal would be a win for Eli Lilly and Novo Nordisk, while Hims & Hers Health would also garner indirect benefits.
/Eli%20Lilly%20%26%20Co_%20by%20Tada%20Images%20via%20Shutterstock.jpg)
While Eli Lilly has slightly lagged behind the SPX over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.
Lilly's capital commitments to expand manufacturing in its home state now total $21 billion since 2020
In LUCENT-3, more than 60% of patients who achieved disease clearance at one year maintained it after four years of continuous Omvoh treatment
INDIANAPOLIS , May 4, 2026 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2026 of $1.73 per share on outstanding common...
Veeva Systems stock pops following S&P 500 inclusion announcement.
Eli Lilly's 2026 is off to a great start, with massive earnings and revenue beats and exciting updates about its latest GLP-1, Foundayo.